| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | GALNT3 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PLCD4 CASR PKD1L2 IDS MAN1A2 USP32 AOC3 DCHS1 CDH1 CDH4 PCDHGC3 | 6.17e-05 | 749 | 138 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 1.42e-04 | 3 | 138 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PLB1 BAAT NDST2 PLCD4 CASR MINPP1 IDS NDST3 PTPRC AGO3 PTPRJ PTPRO SSH3 DBR1 CNOT1 ALPP | 1.47e-04 | 807 | 138 | 16 | GO:0016788 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 1.69e-04 | 16 | 138 | 3 | GO:0016641 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 2.82e-04 | 4 | 138 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 2.82e-04 | 4 | 138 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 2.82e-04 | 4 | 138 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 3.38e-04 | 20 | 138 | 3 | GO:0016638 | |
| GeneOntologyMolecularFunction | ankyrin binding | 5.17e-04 | 23 | 138 | 3 | GO:0030506 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 DCHS1 CDH1 CDH4 PCDHGC3 CNTN2 | 3.76e-06 | 187 | 134 | 9 | GO:0007156 |
| Domain | FN3 | EPHB4 PAPPA2 COL12A1 MYOM1 TSPOAP1 IGDCC4 PTPRC PTPRJ PTPRO CNTN2 | 7.83e-07 | 185 | 132 | 10 | SM00060 |
| Domain | Cadherin_CS | 1.05e-06 | 109 | 132 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 1.38e-06 | 113 | 132 | 8 | PS00232 | |
| Domain | Cadherin | 1.38e-06 | 113 | 132 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 1.48e-06 | 114 | 132 | 8 | PS50268 | |
| Domain | - | 1.48e-06 | 114 | 132 | 8 | 2.60.40.60 | |
| Domain | CA | 1.58e-06 | 115 | 132 | 8 | SM00112 | |
| Domain | Cadherin-like | 1.68e-06 | 116 | 132 | 8 | IPR015919 | |
| Domain | Cadherin | 1.92e-06 | 118 | 132 | 8 | IPR002126 | |
| Domain | fn3 | 2.27e-06 | 162 | 132 | 9 | PF00041 | |
| Domain | FN3_dom | EPHB4 PAPPA2 COL12A1 MYOM1 TSPOAP1 IGDCC4 PTPRC PTPRJ PTPRO CNTN2 | 2.37e-06 | 209 | 132 | 10 | IPR003961 |
| Domain | Cadherin_tail | 5.94e-06 | 37 | 132 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 5.94e-06 | 37 | 132 | 5 | IPR031904 | |
| Domain | Cadherin_C | 1.13e-05 | 42 | 132 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.13e-05 | 42 | 132 | 5 | PF16492 | |
| Domain | FN3 | 1.21e-05 | 199 | 132 | 9 | PS50853 | |
| Domain | Dynein_light_1/2_CS | 4.96e-05 | 2 | 132 | 2 | IPR019763 | |
| Domain | Cadherin_2 | 9.61e-05 | 65 | 132 | 5 | PF08266 | |
| Domain | Cadherin_N | 9.61e-05 | 65 | 132 | 5 | IPR013164 | |
| Domain | WD40 | 1.23e-04 | 268 | 132 | 9 | SM00320 | |
| Domain | - | NBEAL1 WDR81 NUP43 CORO1B TEP1 WDR11 TECPR2 SEMA4A CFAP57 TBL1X | 1.30e-04 | 333 | 132 | 10 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | NBEAL1 WDR81 NUP43 CORO1B TEP1 WDR11 TECPR2 SEMA4A CFAP57 TBL1X | 1.36e-04 | 335 | 132 | 10 | IPR015943 |
| Domain | WD40_repeat | 1.38e-04 | 272 | 132 | 9 | IPR001680 | |
| Domain | - | 1.48e-04 | 3 | 132 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 1.48e-04 | 3 | 132 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 1.48e-04 | 3 | 132 | 2 | IPR015800 | |
| Domain | Dynein_light | 1.48e-04 | 3 | 132 | 2 | PF01221 | |
| Domain | COPPER_AMINE_OXID_1 | 1.48e-04 | 3 | 132 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 1.48e-04 | 3 | 132 | 2 | PS01165 | |
| Domain | Cu_amine_oxidN2 | 1.48e-04 | 3 | 132 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 1.48e-04 | 3 | 132 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 1.48e-04 | 3 | 132 | 2 | IPR016182 | |
| Domain | Cu_amine_oxid | 1.48e-04 | 3 | 132 | 2 | PF01179 | |
| Domain | DYNEIN_LIGHT_1 | 1.48e-04 | 3 | 132 | 2 | PS01239 | |
| Domain | Dynein_light | 1.48e-04 | 3 | 132 | 2 | SM01375 | |
| Domain | Cu_amine_oxidase_C | 1.48e-04 | 3 | 132 | 2 | IPR015798 | |
| Domain | Dynein_light_chain_typ-1/2 | 1.48e-04 | 3 | 132 | 2 | IPR001372 | |
| Domain | - | 1.48e-04 | 3 | 132 | 2 | 3.30.740.10 | |
| Domain | WD_REPEATS_1 | 1.62e-04 | 278 | 132 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.67e-04 | 279 | 132 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.67e-04 | 279 | 132 | 9 | PS50294 | |
| Domain | WD40_repeat_dom | 2.65e-04 | 297 | 132 | 9 | IPR017986 | |
| Domain | Heparan_SO4_deacetylase | 2.95e-04 | 4 | 132 | 2 | IPR021930 | |
| Domain | HSNSD | 2.95e-04 | 4 | 132 | 2 | PF12062 | |
| Domain | Cu_amine_oxidase | 2.95e-04 | 4 | 132 | 2 | IPR000269 | |
| Domain | Ig-like_fold | EPHB4 PAPPA2 COL12A1 MYOM1 TSPOAP1 OSCAR IGDCC4 IGSF10 PTPRC PTPRJ PTPRO SEMA4A CNTN2 IGSF3 | 4.77e-04 | 706 | 132 | 14 | IPR013783 |
| Domain | WD40 | 5.15e-04 | 259 | 132 | 8 | PF00400 | |
| Domain | - | EPHB4 PAPPA2 COL12A1 MYOM1 TSPOAP1 OSCAR IGDCC4 IGSF10 PTPRC PTPRJ PTPRO CNTN2 IGSF3 | 8.47e-04 | 663 | 132 | 13 | 2.60.40.10 |
| Domain | Cadherin_pro | 1.02e-03 | 7 | 132 | 2 | PF08758 | |
| Domain | Cadherin_pro | 1.35e-03 | 8 | 132 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 1.35e-03 | 8 | 132 | 2 | IPR014868 | |
| Domain | Peptidase_S8_His-AS | 1.73e-03 | 9 | 132 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 1.73e-03 | 9 | 132 | 2 | IPR023828 | |
| Domain | BEACH | 1.73e-03 | 9 | 132 | 2 | PS50197 | |
| Domain | Beach | 1.73e-03 | 9 | 132 | 2 | PF02138 | |
| Domain | - | 1.73e-03 | 9 | 132 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.73e-03 | 9 | 132 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.73e-03 | 9 | 132 | 2 | IPR000409 | |
| Domain | Tyr_Pase_AS | 1.78e-03 | 73 | 132 | 4 | IPR016130 | |
| Domain | PTPc | 2.08e-03 | 36 | 132 | 3 | SM00194 | |
| Domain | Peptidase_S8_subtilisin-rel | 2.15e-03 | 10 | 132 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 2.15e-03 | 10 | 132 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 2.15e-03 | 10 | 132 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 2.15e-03 | 10 | 132 | 2 | PS00138 | |
| Domain | - | 2.62e-03 | 11 | 132 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 2.62e-03 | 11 | 132 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 2.62e-03 | 11 | 132 | 2 | PF00082 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.62e-03 | 39 | 132 | 3 | PS50055 | |
| Domain | PTPase_domain | 3.02e-03 | 41 | 132 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 3.02e-03 | 41 | 132 | 3 | PF00102 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.12e-03 | 12 | 132 | 2 | IPR011041 | |
| Domain | TYR_PHOSPHATASE_1 | 3.24e-03 | 86 | 132 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 3.37e-03 | 87 | 132 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 3.37e-03 | 87 | 132 | 4 | PS50056 | |
| Domain | - | 4.12e-03 | 92 | 132 | 4 | 3.90.190.10 | |
| Domain | N2O_reductase_N | 4.90e-03 | 15 | 132 | 2 | IPR011045 | |
| Domain | Prot-tyrosine_phosphatase-like | 5.35e-03 | 99 | 132 | 4 | IPR029021 | |
| Domain | WD40_repeat_CS | 6.21e-03 | 164 | 132 | 5 | IPR019775 | |
| Domain | Furin_repeat | 7.04e-03 | 18 | 132 | 2 | IPR006212 | |
| Domain | FU | 7.04e-03 | 18 | 132 | 2 | SM00261 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 6.94e-07 | 74 | 145 | 6 | 10817752 | |
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 2.45e-06 | 7 | 145 | 3 | 15978577 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 9.92e-06 | 68 | 145 | 5 | 11230163 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 FRAS1 ABCB7 COL12A1 GALNT3 TMTC2 MINPP1 SLC3A2 IGSF10 PLA2R1 MAN1A2 PTPRJ MANEAL FURIN SLC22A3 PRSS21 IGSF3 | 1.16e-05 | 1201 | 145 | 17 | 35696571 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.31e-05 | 72 | 145 | 5 | 10380929 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25386896 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 30082414 | ||
| Pubmed | Affinity, avidity, and kinetics of target sequence binding to LC8 dynein light chain isoforms. | 1.73e-05 | 2 | 145 | 2 | 20889982 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22078799 | ||
| Pubmed | CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression. | 1.73e-05 | 2 | 145 | 2 | 27783992 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18249142 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 23580664 | ||
| Pubmed | Hairless plays a role in formation of inner root sheath via regulation of Dlx3 gene. | 1.73e-05 | 2 | 145 | 2 | 22442153 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12417402 | ||
| Pubmed | The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. | 1.73e-05 | 2 | 145 | 2 | 19588076 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 39031635 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18065418 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12517779 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 27766585 | ||
| Pubmed | 1.82e-05 | 77 | 145 | 5 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.20e-05 | 80 | 145 | 5 | 10716726 | |
| Pubmed | 3.46e-05 | 44 | 145 | 4 | 27505670 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 19246339 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 23943622 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16470615 | ||
| Pubmed | Hereditary defect of the pilosebaceous unit in a new double mutant mouse. | 5.16e-05 | 3 | 145 | 2 | 5774889 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 14585497 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 20304771 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16786001 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 37209565 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 9915799 | ||
| Pubmed | MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. | 5.16e-05 | 3 | 145 | 2 | 10772923 | |
| Pubmed | Dynein light chain LC8 regulates syntaphilin-mediated mitochondrial docking in axons. | 5.16e-05 | 3 | 145 | 2 | 19641106 | |
| Pubmed | Gephyrin interacts with Dynein light chains 1 and 2, components of motor protein complexes. | 5.16e-05 | 3 | 145 | 2 | 12097491 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16167084 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCB7 SPTBN2 NUP43 CTIF CORO1B STIL AGO3 WDR11 DYNLL2 MIB1 DYNLL1 CNOT1 VCPIP1 | 6.27e-05 | 853 | 145 | 13 | 28718761 |
| Pubmed | 7.68e-05 | 20 | 145 | 3 | 22745308 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 22049073 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 11122378 | ||
| Pubmed | Abnormal placental development and early embryonic lethality in EpCAM-null mice. | 1.03e-04 | 4 | 145 | 2 | 20046825 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 23281368 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 18754795 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 9015265 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 31189926 | ||
| Pubmed | Localization of dynein light chains 1 and 2 and their pro-apoptotic ligands. | 1.03e-04 | 4 | 145 | 2 | 14561217 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 16056228 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 12070138 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 16461340 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 29688404 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 26056142 | ||
| Pubmed | 1.18e-04 | 23 | 145 | 3 | 36973253 | ||
| Pubmed | 1.35e-04 | 24 | 145 | 3 | 12403705 | ||
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 28926625 | ||
| Pubmed | A potential role of R-cadherin in striated muscle formation. | 1.71e-04 | 5 | 145 | 2 | 9224674 | |
| Pubmed | JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. | 1.71e-04 | 5 | 145 | 2 | 12591950 | |
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 31505170 | ||
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 12865344 | ||
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 11087757 | ||
| Pubmed | 2.15e-04 | 28 | 145 | 3 | 24322204 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 DOCK3 FRAS1 LONRF1 AOC2 CORO1B TEP1 RNF43 DIP2A PSME4 UCKL1 FURIN IGSF3 HR | 2.26e-04 | 1105 | 145 | 14 | 35748872 |
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 23665428 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 26063811 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 8612964 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 37821496 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 23092738 | ||
| Pubmed | 3.22e-04 | 32 | 145 | 3 | 12493773 | ||
| Pubmed | The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. | 3.58e-04 | 7 | 145 | 2 | 20921139 | |
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 3.58e-04 | 7 | 145 | 2 | 11839813 | |
| Pubmed | The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). | 3.58e-04 | 7 | 145 | 2 | 12370829 | |
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 10844022 | ||
| Pubmed | Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant. | 3.58e-04 | 7 | 145 | 2 | 21948523 | |
| Pubmed | Altered heparan sulfate structure in mice with deleted NDST3 gene function. | 3.58e-04 | 7 | 145 | 2 | 18385133 | |
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 1932742 | ||
| Pubmed | 4.75e-04 | 8 | 145 | 2 | 31286874 | ||
| Pubmed | 4.75e-04 | 8 | 145 | 2 | 24067353 | ||
| Pubmed | 4.75e-04 | 8 | 145 | 2 | 7750641 | ||
| Pubmed | 5.38e-04 | 89 | 145 | 4 | 36861887 | ||
| Pubmed | Genetic epistasis between heparan sulfate and FGF-Ras signaling controls lens development. | 6.10e-04 | 9 | 145 | 2 | 21536023 | |
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 12522767 | ||
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 22497843 | ||
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 15599401 | ||
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 27775065 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.36e-04 | 565 | 145 | 9 | 25468996 | |
| Pubmed | 7.59e-04 | 257 | 145 | 6 | 16335952 | ||
| Pubmed | 7.60e-04 | 10 | 145 | 2 | 9328433 | ||
| Pubmed | 7.60e-04 | 10 | 145 | 2 | 26416966 | ||
| Pubmed | Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis. | 7.60e-04 | 10 | 145 | 2 | 20043899 | |
| Pubmed | 9.26e-04 | 11 | 145 | 2 | 30070635 | ||
| Pubmed | Ocular anterior segment dysgenesis upon ablation of p120 catenin in neural crest cells. | 9.26e-04 | 11 | 145 | 2 | 22736606 | |
| Pubmed | 9.26e-04 | 11 | 145 | 2 | 37225424 | ||
| Pubmed | 9.26e-04 | 11 | 145 | 2 | 26114487 | ||
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 9.26e-04 | 11 | 145 | 2 | 15944372 | |
| Pubmed | 9.26e-04 | 11 | 145 | 2 | 16412416 | ||
| Pubmed | 9.26e-04 | 11 | 145 | 2 | 26256211 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 9.26e-04 | 11 | 145 | 2 | 7493641 | |
| Pubmed | 9.65e-04 | 104 | 145 | 4 | 9205841 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 1.01e-03 | 47 | 145 | 3 | 19167335 | |
| Pubmed | A YY1-dependent increase in aerobic metabolism is indispensable for intestinal organogenesis. | 1.11e-03 | 12 | 145 | 2 | 27802136 | |
| Pubmed | RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. | 1.11e-03 | 12 | 145 | 2 | 29769720 | |
| Pubmed | 1.11e-03 | 12 | 145 | 2 | 12460940 | ||
| Interaction | PCDHGA6 interactions | 3.83e-07 | 24 | 129 | 5 | int:PCDHGA6 | |
| Interaction | PCDHGB2 interactions | 8.84e-06 | 44 | 129 | 5 | int:PCDHGB2 | |
| Interaction | PCDHGB3 interactions | 1.40e-05 | 8 | 129 | 3 | int:PCDHGB3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 2.58e-07 | 271 | 147 | 9 | chr7q11 |
| Cytoband | 5q31 | 2.05e-06 | 115 | 147 | 6 | 5q31 | |
| Cytoband | 7q11.23 | 2.77e-04 | 97 | 147 | 4 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.18e-04 | 298 | 147 | 6 | chr5q31 | |
| Cytoband | 17q21 | 1.11e-03 | 63 | 147 | 3 | 17q21 | |
| Cytoband | 1p13 | 1.34e-03 | 17 | 147 | 2 | 1p13 | |
| GeneFamily | Fibronectin type III domain containing | 3.01e-07 | 160 | 102 | 9 | 555 | |
| GeneFamily | Clustered protocadherins | 3.03e-05 | 64 | 102 | 5 | 20 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.70e-05 | 12 | 102 | 3 | 756 | |
| GeneFamily | WD repeat domain containing | 1.18e-04 | 262 | 102 | 8 | 362 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.15e-04 | 21 | 102 | 3 | 813 | |
| GeneFamily | CD molecules|Type I classical cadherins | 3.12e-04 | 5 | 102 | 2 | 1185 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.11e-03 | 9 | 102 | 2 | 1230 | |
| GeneFamily | Dyneins, cytoplasmic | 2.36e-03 | 13 | 102 | 2 | 538 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.79e-09 | 178 | 141 | 9 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 196 | 141 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.26e-07 | 197 | 141 | 8 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-06 | 166 | 141 | 7 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 193 | 141 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 193 | 141 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 194 | 141 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-06 | 195 | 141 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 196 | 141 | 7 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 196 | 141 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 196 | 141 | 7 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.19e-06 | 197 | 141 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.19e-06 | 197 | 141 | 7 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-06 | 197 | 141 | 7 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-06 | 197 | 141 | 7 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-06 | 198 | 141 | 7 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.30e-06 | 198 | 141 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-06 | 200 | 141 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 131 | 141 | 6 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-06 | 137 | 141 | 6 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-06 | 150 | 141 | 6 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 157 | 141 | 6 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 162 | 141 | 6 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 162 | 141 | 6 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 164 | 141 | 6 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 141 | 6 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 177 | 141 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 177 | 141 | 6 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-05 | 181 | 141 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 183 | 141 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 185 | 141 | 6 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 185 | 141 | 6 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 3.02e-05 | 188 | 141 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.02e-05 | 188 | 141 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-05 | 188 | 141 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.11e-05 | 189 | 141 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.11e-05 | 189 | 141 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 189 | 141 | 6 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.11e-05 | 189 | 141 | 6 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 189 | 141 | 6 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.20e-05 | 190 | 141 | 6 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 191 | 141 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 141 | 6 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 192 | 141 | 6 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-05 | 192 | 141 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-05 | 193 | 141 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.49e-05 | 193 | 141 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-05 | 193 | 141 | 6 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.49e-05 | 193 | 141 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.49e-05 | 193 | 141 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.49e-05 | 193 | 141 | 6 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-05 | 194 | 141 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 194 | 141 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-05 | 194 | 141 | 6 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.60e-05 | 194 | 141 | 6 | 3c661c6768c3f05d2aba03d329adb257ca201b2d | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.60e-05 | 194 | 141 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.60e-05 | 194 | 141 | 6 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 195 | 141 | 6 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 3.70e-05 | 195 | 141 | 6 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.81e-05 | 196 | 141 | 6 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-05 | 197 | 141 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.92e-05 | 197 | 141 | 6 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 197 | 141 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 199 | 141 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.14e-05 | 199 | 141 | 6 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 199 | 141 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 199 | 141 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.18e-05 | 121 | 141 | 5 | 392700c5032b83d4d4e191fea9bcd170e4567b9d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-05 | 200 | 141 | 6 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 126 | 141 | 5 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 126 | 141 | 5 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 126 | 141 | 5 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 126 | 141 | 5 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 126 | 141 | 5 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.10e-05 | 131 | 141 | 5 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-05 | 131 | 141 | 5 | aeeb5718b3a7122492ad2659d5c8112f60839ff3 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 143 | 141 | 5 | 4d11d53330a9197275a8851e1bbf55a113715a09 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 143 | 141 | 5 | 8b9f4d87d5faac7752c83e1992491fc5550600f8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 149 | 141 | 5 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 151 | 141 | 5 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 152 | 141 | 5 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| Drug | Lilly 51641 | 1.41e-07 | 9 | 134 | 4 | CID000021485 | |
| Drug | spermic acid | 7.94e-07 | 4 | 134 | 3 | CID000167029 | |
| Drug | lanthionamine | 7.94e-07 | 4 | 134 | 3 | CID000070096 | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A | 2.50e-06 | 196 | 134 | 9 | 4683_DN | |
| Drug | iproniazid | 6.35e-06 | 21 | 134 | 4 | CID000003748 | |
| Drug | putreanine | 6.86e-06 | 7 | 134 | 3 | CID000161506 | |
| Drug | p-dimethylaminomethylbenzylamine | 6.86e-06 | 7 | 134 | 3 | CID000193714 | |
| Drug | phenylhydrazine | 9.01e-06 | 82 | 134 | 6 | CID000007516 | |
| Drug | Q 192 | 1.09e-05 | 8 | 134 | 3 | CID000077317 | |
| Drug | semicarbazide | 1.24e-05 | 51 | 134 | 5 | CID000005196 | |
| Drug | benzylamine | 1.36e-05 | 52 | 134 | 5 | CID000007504 | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.60e-05 | 188 | 134 | 8 | 7104_UP | |
| Drug | p-nitrophenylhydrazine | 1.63e-05 | 9 | 134 | 3 | CID000069472 | |
| Drug | sevelamer | 1.81e-05 | 27 | 134 | 4 | CID003085017 | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.01e-05 | 194 | 134 | 8 | 6616_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.16e-05 | 196 | 134 | 8 | 5022_DN | |
| Drug | acetylcadaverine | 2.32e-05 | 10 | 134 | 3 | CID000189087 | |
| Drug | pargyline | 2.37e-05 | 97 | 134 | 6 | CID000004688 | |
| Drug | 25(OH) vitamin D3 | 3.06e-05 | 150 | 134 | 7 | CID000001593 | |
| Drug | DPGBG | 3.44e-05 | 2 | 134 | 2 | CID005356884 | |
| Drug | monopropionylcadaverine | 3.44e-05 | 2 | 134 | 2 | CID000194207 | |
| Drug | 1-carboxymethylpyridinium | 3.44e-05 | 2 | 134 | 2 | CID000080439 | |
| Drug | supinidine | 3.44e-05 | 2 | 134 | 2 | CID000164663 | |
| Drug | diphenylglyoxal bis(guanylhydrazone | 3.44e-05 | 2 | 134 | 2 | CID000357080 | |
| Drug | AC1Q77R6 | 3.44e-05 | 2 | 134 | 2 | CID000094259 | |
| Drug | p-dimethylaminomethylbenzaldehyde | 3.44e-05 | 2 | 134 | 2 | CID000193251 | |
| Drug | isoputreanine | 3.44e-05 | 2 | 134 | 2 | CID000171763 | |
| Drug | N-(3-aminopropyl)pyrrolidin-2-one | 3.44e-05 | 2 | 134 | 2 | CID000082111 | |
| Drug | imidazole acetaldehyde | 4.22e-05 | 12 | 134 | 3 | CID000150841 | |
| Drug | Dons | 5.46e-05 | 13 | 134 | 3 | CID000193668 | |
| Drug | sulfite | PCDHGB7 LONRF1 IDS IGDCC4 PLA2R1 PTPRO SLC22A3 PRSS21 CDH1 PCDHGC3 SLC4A9 | 5.81e-05 | 438 | 134 | 11 | CID000001099 |
| Drug | MDL 72145 | 6.92e-05 | 14 | 134 | 3 | CID006438383 | |
| Drug | benzylhydrazine | 6.92e-05 | 14 | 134 | 3 | CID000011157 | |
| Drug | N1-acetylspermine | 6.92e-05 | 14 | 134 | 3 | CID000000916 | |
| Drug | tele-methylhistamine | 7.25e-05 | 38 | 134 | 4 | CID000003614 | |
| Drug | Apal | 8.61e-05 | 15 | 134 | 3 | CID003082547 | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT_HG-U133A | 8.73e-05 | 177 | 134 | 7 | 4495_UP | |
| Drug | AC1L1B7L | 1.03e-04 | 3 | 134 | 2 | CID000026477 | |
| Drug | (+)-Cyanustine | 1.03e-04 | 3 | 134 | 2 | CID000028846 | |
| Drug | propylglyoxal | 1.03e-04 | 3 | 134 | 2 | CID000123249 | |
| Drug | 3-Hydroxycadaverine | 1.03e-04 | 3 | 134 | 2 | CID000435285 | |
| Drug | 5-fluoropentane-1,4-diamine | 1.03e-04 | 3 | 134 | 2 | CID010011890 | |
| Drug | NSD-1531 | 1.03e-04 | 3 | 134 | 2 | CID003014318 | |
| Drug | necic acid | 1.03e-04 | 3 | 134 | 2 | CID006440847 | |
| Drug | AC1L34PU | 1.03e-04 | 3 | 134 | 2 | CID000134498 | |
| Drug | N-(4-aminobutyl)aziridine | 1.03e-04 | 3 | 134 | 2 | CID000152643 | |
| Drug | alpha-difluoromethyl putrescine | 1.03e-04 | 3 | 134 | 2 | CID000135151 | |
| Drug | ketosuccinamate | 1.03e-04 | 3 | 134 | 2 | CID000439716 | |
| Drug | N-(3-aminopropyl)aziridine | 1.03e-04 | 3 | 134 | 2 | CID000014076 | |
| Drug | 3-aminopropionamide | 1.03e-04 | 3 | 134 | 2 | CID000192802 | |
| Drug | pentafluorobenzamide | 1.03e-04 | 3 | 134 | 2 | CID000069547 | |
| Drug | acisoga | 1.03e-04 | 3 | 134 | 2 | CID000129397 | |
| Drug | frentizole | 1.03e-04 | 3 | 134 | 2 | CID000033334 | |
| Drug | Nazlinine | 1.03e-04 | 3 | 134 | 2 | CID000126237 | |
| Drug | 5-aminopentanal | 1.03e-04 | 3 | 134 | 2 | CID000443849 | |
| Drug | h202 | 1.03e-04 | 3 | 134 | 2 | CID000013826 | |
| Drug | amicarbalide | 1.03e-04 | 3 | 134 | 2 | CID000072074 | |
| Drug | C10974 | 1.03e-04 | 3 | 134 | 2 | CID000443042 | |
| Drug | ethylmethylglyoxal bis(guanylhydrazone | 1.03e-04 | 3 | 134 | 2 | CID000129202 | |
| Drug | PQQ cofactor | 1.06e-04 | 16 | 134 | 3 | CID000363188 | |
| Drug | MDL 72527 | 1.06e-04 | 16 | 134 | 3 | CID000004026 | |
| Drug | NSC142627 | 1.28e-04 | 17 | 134 | 3 | CID000422254 | |
| Drug | methylimidazole acetaldehyde | 1.28e-04 | 17 | 134 | 3 | CID000193545 | |
| Drug | guazatine | 1.52e-04 | 18 | 134 | 3 | CID000003526 | |
| Drug | 5-fluoromethylornithine | 1.52e-04 | 18 | 134 | 3 | CID000119351 | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 6835_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 3641_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 3530_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 5975_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 6785_UP | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 2536_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 3233_UP | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; HL60; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 2143_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 3239_DN | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 6327_UP | |
| Drug | Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 7465_UP | |
| Drug | malonamate | 2.05e-04 | 4 | 134 | 2 | CID000075367 | |
| Drug | Eovist (TN) | 2.05e-04 | 4 | 134 | 2 | CID009961939 | |
| Drug | N-acetyl-1,6-diaminohexane | 2.05e-04 | 4 | 134 | 2 | CID000162081 | |
| Drug | 3-aminooxy-2-fluoro-1-propanamine | 2.05e-04 | 4 | 134 | 2 | CID000126496 | |
| Drug | 2-Butene-1,4-diamine | 2.05e-04 | 4 | 134 | 2 | CID000148401 | |
| Drug | N-methylpyrrolinium | 2.05e-04 | 4 | 134 | 2 | CID000440932 | |
| Drug | 1,4-diamino-2-butyne | 2.05e-04 | 4 | 134 | 2 | CID000124159 | |
| Drug | 2-aminoresorcinol | 2.05e-04 | 4 | 134 | 2 | CID000069450 | |
| Drug | AC1Q3E6A | 2.05e-04 | 4 | 134 | 2 | CID000068318 | |
| Drug | 16 beta-hydroxydigitoxigenin | 2.05e-04 | 4 | 134 | 2 | CID000011012 | |
| Drug | dimethylpyridine | 2.05e-04 | 4 | 134 | 2 | CID000011420 | |
| Drug | tiludronate | 2.11e-04 | 20 | 134 | 3 | CID000060936 | |
| Drug | N1-acetylspermidine | 2.11e-04 | 20 | 134 | 3 | CID000000496 | |
| Drug | AC1L1CLB | 2.14e-04 | 92 | 134 | 5 | CID000001951 | |
| Drug | CTK2H7103 | 2.44e-04 | 209 | 134 | 7 | CID005462309 | |
| Drug | panobinostat | SOX3 FRAS1 GALNT3 TSPOAP1 TSHZ2 GLIS3 TEP1 RNF43 ST6GALNAC2 NPFFR2 HHIP DENND1B PTPRO MANEAL DLX3 NQO2 CDH1 CNTN2 FOXC1 | 3.04e-04 | 1333 | 134 | 19 | ctd:C496932 |
| Drug | AC1L3XA1 | 3.24e-04 | 23 | 134 | 3 | CID000123782 | |
| Drug | hydroxyl radicals | AMT CYP27A1 AOC2 BAAT PLCD4 CORO1B MINPP1 USP21 ADHFE1 MAN1A2 PTPRC PIGA PTPRJ PTPRO SCD UCKL1 USP32 AOC3 ALPP | 3.27e-04 | 1341 | 134 | 19 | CID000000961 |
| Drug | amiguanidine | 3.40e-04 | 5 | 134 | 2 | CID000364439 | |
| Drug | geranylamine | 3.40e-04 | 5 | 134 | 2 | CID000160248 | |
| Drug | allyl formate | 3.40e-04 | 5 | 134 | 2 | CID000061278 | |
| Drug | phenamidine | 3.40e-04 | 5 | 134 | 2 | CID000064948 | |
| Drug | 1-penten-3-ol | 3.40e-04 | 5 | 134 | 2 | CID000012020 | |
| Drug | NSD 1024 | 3.40e-04 | 5 | 134 | 2 | CID000188951 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.00e-06 | 71 | 137 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | delivery measurement, spontaneous preterm birth | 2.14e-05 | 2 | 137 | 2 | EFO_0006917, EFO_0006922 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 8.98e-05 | 19 | 137 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 8.98e-05 | 19 | 137 | 3 | C2936783 | |
| Disease | autosomal recessive congenital ichthyosis 4B (implicated_via_orthology) | 1.28e-04 | 4 | 137 | 2 | DOID:0060713 (implicated_via_orthology) | |
| Disease | cysteine-rich secretory protein LCCL domain-containing 2 measurement | 1.28e-04 | 4 | 137 | 2 | EFO_0801512 | |
| Disease | mental development measurement | 2.09e-04 | 25 | 137 | 3 | EFO_0008230 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.12e-04 | 5 | 137 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.35e-04 | 26 | 137 | 3 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.64e-04 | 27 | 137 | 3 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 3.27e-04 | 29 | 137 | 3 | C1333990 | |
| Disease | renin measurement | 5.88e-04 | 8 | 137 | 2 | EFO_0010616 | |
| Disease | asthma | DOCK3 CRISPLD2 MAGI1 SPEM2 GLIS3 TMTC2 CASR PTPRC SUGCT FURIN USP32 | 7.85e-04 | 751 | 137 | 11 | MONDO_0004979 |
| Disease | testosterone measurement | DOCK3 MAGI1 CACNA1D SPEM3 TSHZ2 BCORL1 GLIS3 WDR81 DENND1B PTPRJ WDR11 SUGCT SLC22A3 FOXC1 TBL1X | 8.81e-04 | 1275 | 137 | 15 | EFO_0004908 |
| Disease | Hand-foot syndrome, response to fluoropyrimidines | 1.15e-03 | 11 | 137 | 2 | EFO_0010825, EFO_1001893 | |
| Disease | multiple sclerosis symptom measurement | 1.28e-03 | 46 | 137 | 3 | EFO_0803536 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.76e-03 | 60 | 137 | 3 | C4722327 | |
| Disease | response to opioid | 2.89e-03 | 61 | 137 | 3 | EFO_0008541 | |
| Disease | mean platelet volume | PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 BCORL1 CASR STIL BCLAF3 PTPRC PTPRJ SCD PCDHGC3 | 2.91e-03 | 1020 | 137 | 12 | EFO_0004584 |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 3.03e-03 | 62 | 137 | 3 | EFO_0004616, EFO_1000786 | |
| Disease | Disorder of eye | 3.17e-03 | 212 | 137 | 5 | C0015397 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 3.47e-03 | 19 | 137 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Deaf Mutism | 3.85e-03 | 20 | 137 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 3.85e-03 | 20 | 137 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 3.85e-03 | 20 | 137 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 3.85e-03 | 20 | 137 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 3.85e-03 | 20 | 137 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 3.85e-03 | 20 | 137 | 2 | C0011052 | |
| Disease | Prostate cancer, familial | 4.10e-03 | 69 | 137 | 3 | C2931456 | |
| Disease | BREAST CANCER | 4.24e-03 | 21 | 137 | 2 | 114480 | |
| Disease | cataract | 4.30e-03 | 141 | 137 | 4 | MONDO_0005129 | |
| Disease | bipolar disorder, body mass index | 4.62e-03 | 72 | 137 | 3 | EFO_0004340, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRWGTAHGSIVPYQA | 266 | Q9HAC7 | |
| HYNQTTGTRPCWGST | 181 | Q96Q91 | |
| RHGKNNWTLLSYPGA | 346 | Q14032 | |
| SGRPTHHGYSQNRRW | 236 | O43310 | |
| WNPRTGTINDFSYLH | 851 | Q8IUX7 | |
| PSNRSWHRGYDSGNV | 961 | Q86UK0 | |
| LALTWHTSAYGPDQR | 11 | P41180 | |
| RYGASLELPTHQGWT | 581 | Q8NFD2 | |
| VGWSPYHQASLLSIG | 831 | Q5H9F3 | |
| PDLIYNVSWNHNGSL | 176 | Q9BR76 | |
| WNGGTPLLYAVHGNH | 246 | Q9H9E1 | |
| GIQGTSRPSHYHVLW | 756 | Q9H9G7 | |
| DPTNSWYHAQNLSGP | 246 | O60479 | |
| SNHSNKWGHPRGYRI | 591 | Q16853 | |
| NAQPWHSGVYVCRAN | 301 | Q8TDY8 | |
| VNQQWTTAHYHTGPG | 111 | Q8NFH3 | |
| PGTDWTVFQINHSAY | 216 | O95803 | |
| IGTHGWLPYDRNISN | 2356 | Q6ZS30 | |
| HWLAFGNSSVNPIIY | 421 | Q9Y5X5 | |
| TWVPGNSNLAHAIYL | 901 | O95153 | |
| RKHYPWVQLSGHAGN | 406 | Q96DU7 | |
| SGHSSYAIAWHQQQP | 46 | A0A075B6H9 | |
| NAWLSYHVLQASEPG | 601 | Q9Y5F9 | |
| NAWLSYHVVQASEPG | 601 | Q9Y5F8 | |
| NAWGHQRGYRIQIHS | 591 | O75106 | |
| NQPSYAGWTALHEAS | 516 | Q8N7Z5 | |
| SLYSPHNLNANGGWQ | 396 | P40426 | |
| GQVTYSLAPGAHTHW | 506 | Q96JQ0 | |
| DHVWGDPNSTAQYTR | 611 | Q12913 | |
| PVHSTLNQWRNGYSP | 676 | A0AUZ9 | |
| LASSARSANWPYGHR | 561 | P58215 | |
| EGIVWYRHSGAPAQS | 1416 | Q86XX4 | |
| YSRQPNEHHTWNGTS | 1301 | Q96QZ7 | |
| QRQPHYSAFGSVGEW | 901 | P54760 | |
| NYRLRHGLGWSAAPV | 96 | Q17RB8 | |
| SFQRGEPQNYLAHTW | 191 | Q96MR6 | |
| NPTWHCIVGRNFGSY | 51 | P63167 | |
| PQLWAAYGVSPHRGH | 986 | O43593 | |
| HSDGNTYLSWLQQRP | 51 | A0A075B6R9 | |
| NAWLSYHVLQASEPG | 601 | Q9Y5G2 | |
| AHWGRYRSPGFHVQS | 116 | Q9H0B8 | |
| NAWLSYHIVQASEPG | 601 | Q9Y5G1 | |
| GHNAWLSYSLLGSPN | 601 | Q9UN70 | |
| VNGDSRYFLWPLQHG | 161 | P16083 | |
| VTYSNWHGGQAAAAP | 111 | Q7Z442 | |
| ASSPHSAAYVLWDNG | 186 | Q86YT6 | |
| NYTAWPDHGVPTANA | 1096 | Q16827 | |
| VAAPLQYRHSAQPWA | 166 | Q8IYS5 | |
| YNVSSWADRHPGGHQ | 81 | A8MWK0 | |
| GHRYNNGHWSSSPPQ | 351 | Q3B8N5 | |
| ASPAGTYAHTVNRNW | 176 | P05187 | |
| HSRYQPGTWTHVAAT | 356 | Q9BXP8 | |
| QHRVGSWIHVYPNGS | 1986 | Q6WRI0 | |
| SWIHVYPNGSLFIGS | 1991 | Q6WRI0 | |
| SHITIWCNVSGYQGP | 36 | O75054 | |
| TDQWNLGPQTYRHAE | 251 | A2AJT9 | |
| SFVLYHSNSPRWGEI | 476 | Q8IZD9 | |
| GGALGNRHAVYWNSS | 26 | P52797 | |
| NWSPAGENVFSYHIT | 651 | Q99715 | |
| NWRVDVTLPSSYHGA | 1796 | Q9Y6R7 | |
| HQGRLTSWYLNQAGG | 466 | Q12948 | |
| PYGSNHNRGNFDWSL | 321 | Q14435 | |
| GLNPNHIHIYSASWG | 241 | P09958 | |
| EWSQGYRALPSLSNH | 71 | Q8NEA6 | |
| PFTTEGHHWYQLRQA | 146 | Q02318 | |
| PHSPNWNAVYRIISG | 421 | P55283 | |
| WNAVYRIISGDPSGH | 426 | P55283 | |
| AGPGLFSYIRHWDQN | 546 | P08195 | |
| THWQTARVPGADAQY | 756 | Q02246 | |
| ISRWHNQGLPHGQYS | 2496 | Q0VDD8 | |
| GYIDTSIRPWNNHNT | 361 | Q5VSG8 | |
| NPRTGRWGQYHTSVG | 381 | O60476 | |
| SDPHLYVWNATGNRL | 546 | Q86Z14 | |
| HSDGNTYLSWLQQRP | 51 | A0A0C4DH68 | |
| PENNGLHARWDYSAT | 306 | Q9UK59 | |
| NSYWRVHAGNFSTIP | 106 | P22304 | |
| LGEIWVSSPHNATGY | 1386 | Q14689 | |
| AFAGWSLPVQYRDSH | 51 | P48728 | |
| FCGGNPRSYQQWVHT | 411 | Q6P3S1 | |
| QGSHVTRWPGFYILQ | 621 | Q92503 | |
| PCRGGWRYAQAHSTI | 126 | O75751 | |
| QVNGSLPSLHRSSWY | 2011 | Q01668 | |
| WLQGFGRPSVYHAAI | 36 | Q5SR56 | |
| THGASANWTIQYNDP | 631 | P12830 | |
| NPTWHCIVGRNFGSY | 51 | Q96FJ2 | |
| AYQGSNPISDIWAIH | 271 | Q8IWW8 | |
| NSPHSRYLAEWPQGV | 46 | Q9H195 | |
| QAVHLWRFSGGYPAL | 121 | Q9BPW8 | |
| GPAWINLYGSPRNHS | 361 | Q2WGJ9 | |
| IIQTHYQPWGFLSAA | 1131 | Q8N2Y8 | |
| QRLDTYTHVNGWANG | 256 | P41225 | |
| FIWAIRHPASGYVQG | 296 | Q9NU19 | |
| QHNTWQLSRVYPSGL | 541 | Q9BRC7 | |
| GAALAAQQSYWPHFV | 671 | Q9H3S1 | |
| PYAQGWGLSHLQSTS | 411 | Q68DV7 | |
| FSRAGLPSWQYQRIH | 146 | P0DUX0 | |
| FSRAGLPSWQYQRIH | 146 | P0DTA3 | |
| FSRAGLPSWQYQRIH | 146 | P0DUD1 | |
| SQHKAPYGWRGLSHQ | 106 | Q9UJ37 | |
| PYGWRGLSHQVIAST | 111 | Q9UJ37 | |
| NHIYTWVDPQGRSIS | 231 | Q9P202 | |
| AEVSRQYHGTWLSPA | 221 | Q6P1J6 | |
| VSYTTNQERWAIGPH | 301 | Q96QV1 | |
| VQYTHWNTHQPRYSG | 601 | Q13018 | |
| PGGSALTWASHYQER | 221 | Q8TE77 | |
| WRPHQLGALGTARAY | 41 | O75027 | |
| VHLSPAWAYAAVGLN | 876 | Q7Z7M1 | |
| SHFNWPVQGANYHVL | 66 | A6NNL5 | |
| LHYAWHGQGQSPSIR | 521 | A5YKK6 | |
| DATGPRGAWTNNYSH | 456 | P37287 | |
| IWNTQSGNLVHSYRG | 531 | O60907 | |
| HIQYSPLNSWQGANT | 611 | Q15468 | |
| NRHPGWSRGSVAYHA | 286 | Q8NCJ5 | |
| SSPGHWKQQGQQYSH | 146 | Q6P1L6 | |
| QTGWHVYNDSRVSPV | 526 | Q9UK80 | |
| HFHWAQQYPSGRSVT | 991 | Q99973 | |
| WDTVRGQLAFQHTYP | 1786 | Q99973 | |
| SAAFLQGLWQHYHPG | 191 | Q9UNW1 | |
| AGYPNVNVHNFTTSW | 191 | O15020 | |
| QSYGRHGSQSRLWGN | 256 | Q0P670 | |
| WRAGSQHGAYRPVDT | 1106 | A0A1B0GUW6 | |
| FSRAGLPSWQYQRIH | 146 | P0DUX1 | |
| FSRAGLPSWQYQRIH | 146 | A0A494C0Z2 | |
| FSRAGLPSWQYQRIH | 146 | P0DUD3 | |
| FSRAGLPSWQYQRIH | 146 | P0DUD4 | |
| FSRAGLPSWQYQRIH | 146 | P0DUD2 | |
| SRAGLPSWQYQRIHF | 431 | A6NKU9 | |
| HGSYSNAPQHIWSEN | 361 | Q9NV64 | |
| NHAIGGLNPWSYHLV | 76 | Q8N394 | |
| LGATWIHGSHGNPIY | 76 | Q9NWM0 | |
| NYSYGEATHWPNSGR | 326 | P29144 | |
| SWYQHQRAHGDPVAL | 711 | P52849 | |
| GAVLSPAWVTADHQY | 36 | Q9BQJ4 | |
| TWLVNSAAHLFGYRP | 261 | O00767 | |
| GTYWNHVVPRGTASA | 1106 | O15040 | |
| AWSSSGRNHYIPLVG | 346 | Q96JH7 | |
| SITSFYHPSNNGRWL | 336 | Q14997 | |
| SGHRSVSWYQQTPGQ | 46 | A0A578 | |
| AQNGAPSWSAYPSIH | 531 | Q9NRE2 | |
| HYASRPGDWHQPVSG | 71 | Q96JE7 | |
| QPAIQHWYLTSSGRR | 1081 | O60290 | |
| TAGRPPWYNEHGTQS | 81 | Q9NWZ5 | |
| FSRAGLPSWQYQRIH | 146 | A0A494C191 | |
| NRPGVYTNISHHFEW | 266 | Q9Y6M0 | |
| HQPWNGQYSLDISHV | 861 | Q9BZH6 | |
| LPSYRSWRTQHIGNQ | 951 | P08575 | |
| SRYGLQAGHNWFIIS | 386 | Q8NFA0 | |
| LPRSVHGLSGNWLAY | 1606 | Q562E7 | |
| LAYRHGSGAHWNRPV | 146 | P30518 | |
| NWSHNGSAIRYSDRV | 1491 | P52179 | |
| HSYWRQHGTLPAPAG | 301 | Q14957 |